COR logo

Cencora (COR)

Profile

Full Name

Cencora, Inc.

Ticker Symbol

COR

Exchange

NYSE

Sector

Healthcare

Industry

Medical Distribution

Country

United States

IPO

April 4, 1995

Indexes

S&P 500

Website

http://www.cencora.com

Employees

46000

Key Details

Price

$284.29(-0.01%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$293.96B(+12.12% YoY)

Annual EPS

$7.53(-11.72% YoY)

PE ratio

40.55

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$284.29
COR price is $284.29

30-Day Relative Volume

0.58
COR 30-day relative volume is 0.58

Price Performance

Price Today change

-0.01%
COR price is down -0.01% today

Price YTD change

+26.53%
COR price is up +26.53% since January 1st

Price 1-year change

+21.49%
COR price is up +21.49% year-on-year

Price 3-year change

+76.35%
COR price is up +76.35% over the past 3 years

Price Range

Price All-time high

$296.65
COR price is currently -4.17% below its historical high of $296.65

Price 3-year low

$135.14
COR price is currently +110.37% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$12.56B
COR market capitalization is $12.56 billion

Market cap 3-year change

+76.35%
COR market capitalization is up +76.35% over the past 3 years

Market cap All-time high

$12.79B
COR market capitalization is currently -1.75% below its historical high of $12.79 billion

Market cap sector rank

94.25%
COR market capitalization is higher than 94.25% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
COR {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

0%
COR {parameterFullLabel} has remained unchanged over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.00
COR beta is 0.00

200-day SMA

$241.15
COR price is currently +17.89% above its 200-day simple moving average

50-day SMA

$260.24
COR price is currently +9.24% above its 50-day simple moving average

RSI

66.63
COR 14-day relative strength index is 66.63

Volume

0.58
COR 30-day relative volume is 0.58

ATR

$8.73
COR average true range is $8.73

10-day Historical Volatility

31.74%
COR 10-day historical volatility is 31.74%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$293.96B
COR annual revenue is $293.96 billion

Revenue Analysts estimate

$323.12B
COR annual revenue is currently -9.03% lower than the consensus analysts' forecast

Revenue 1-year change

+12.12%
COR annual revenue is up +12.12% year-on-year

Revenue Sector rank

99.66%
COR annual revenue is higher than 99.66% of companies in Healthcare sector

EPS

EPS

$7.53
COR annual earnings per share is $7.53

EPS Analysts estimate

$15.42
COR annual earnings per share is currently -51.16% lower than the consensus analysts' forecast

EPS 1-year change

-11.72%
COR annual earnings per share is down -11.72% year-on-year

EPS Sector rank

97.27%
COR annual earnings per share is higher than 97.27% of companies in Healthcare sector

Profit

Gross profit

$9.91B
COR annual gross profit is $9.91 billion

Gross margin

3.37%
COR annual gross profit margin is 3.37%

Operating profit

$3.16B
COR annual operating income is $3.16 billion

Operating margin

1.07%
COR annual operating profit margin is 1.07%

Net income

$1.51B
COR annual net profit is $1.51 billion

Net margin

-
COR annual net profit margin value is unknown

Expenses

Total expenses

$290.80B
COR annual total expenses is $290.80 billion

Operating expenses

$6.75B
COR annual total operating expenses is $6.75 billion

Cost of goods sold

$284.05B
COR annual cost of goods sold is $284.05 billion

Selling, general & administrative expenses

$5.66B
COR annual SGA is $5.66 billion

Depreciation and amortization

$1.12B
COR annual depreciation & amortization is $1.12 billion

Interest expense

$248.68M
COR annual interest expense is $248.68 million

Income tax

$484.70M
COR annual income tax is $484.70 million

EBIT & EBITDA

EBIT

$2.25B
COR annual earnings before interest & taxes is $2.25 billion

EBITDA

$4.35B
COR annual EBITDA is $4.35 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$67.10B
COR annual total assets is $67.10 billion

Non current assets

$19.38B
COR annual long term assets is $19.38 billion

Current assets

$47.72B
COR annual total current assets is $47.72 billion

Cash and cash equivalents

$3.13B
COR annual cash & cash equivalents is $3.13 billion

Accounts receivable

$23.87B
COR annual accounts receivable is $23.87 billion

Inventory

$19.00B
COR annual inventory is $19.00 billion

Liabilities

Total liabilities

$66.31B
COR annual total liabilities is $66.31 billion

Long term liabilities

$12.04B
COR annual total long term liabilities is $12.04 billion

Current liabilities

$54.28B
COR annual total current liabilities is $54.28 billion

Accounts payable

$50.94B
COR annual accounts payable is $50.94 billion

Debt

Total debt

$4.39B
COR annual total debt is $4.39 billion

Total debt 1-year change

-8.34%
COR annual total debt is down -8.34% year-on-year

Long term debt

$3.81B
COR annual long term debt is $3.81 billion

Short term debt

$576.33M
COR annual short term debt is $576.33 million

Equity & Capital

Shareholders equity

$645.94M
COR annual stockholders equity is $645.94 million

Book value

-$12.67B
COR annual book value is -$12.67 billion

Retained earnings

$5.42B
COR annual retained earnings is $5.42 billion

Working capital

-$6.56B
COR annual working capital is -$6.56 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$3.48B
COR annual cash flow from operations is $3.48 billion

Cash from operations 1-year change

-10.91%
COR annual cash flow from operations is down -10.91% year-on-year

Cash from investing

-$618.10M
COR annual cash flow from investing activities is -$618.10 million

Cash from investing 1-year change

+76.25%
COR annual cash flow from investing activities is up +76.25% year-on-year

Cash from financing

-$2.33B
COR annual cash flow from financing activities is -$2.33 billion

Cash from financing 1-year change

-4.89%
COR annual cash flow from financing activities is down -4.89% year-on-year

CAPEX

CAPEX

$487.17M
COR annual capital expenditures is $487.17 million

CAPEX 1-year change

+6.29%
COR annual capital expenditures is up +6.29% year-on-year

Free Cash Flow

Free cash flow

$3.00B
COR annual free cash flow is $3.00 billion

Free cash flow 1-year change

-13.19%
COR annual free cash flow is down -13.19% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

3.37%
COR annual gross profit margin is 3.37%

Operating margin

1.07%
COR annual operating profit margin is 1.07%

Net margin

-
COR annual net profit margin value is unknown

ROA & ROE

ROA

2.25%
COR annual return on assets is 2.25%

ROE

233.63%
COR annual return on equity is 233.63%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

40.55
COR price to earnings ratio is 40.55

PE ratio Sector rank

73.04%
COR price to earnings ratio is higher than 73.04% of companies in Healthcare sector

PB Ratio

PB ratio

-0.99
COR price to book ratio is -0.99

PB ratio Sector rank

8.31%
COR price to book ratio is higher than 8.31% of companies in Healthcare sector

PS Ratio

PS ratio

0.04
COR price to sales ratio is 0.04

PS ratio Sector rank

3.33%
COR price to sales ratio is higher than 3.33% of companies in Healthcare sector

Enterprise value

Enterprise value

$17.49B
COR enterprise value is $17.49 billion

Enterprise value Sector rank

94.3%
COR enterprise value is higher than 94.3% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

4.05
COR EV/EBITDA is 4.05

EV/EBITDA Sector rank

77.85%
COR EV/EBITDA is higher than 77.85% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.88
COR annual current ratio is 0.88

Quick ratio

0.53
COR annual quick ratio is 0.53

Leverage

Debt to equity

6.79
COR annual debt to equity ratio is 6.79

Interest coverage ratio

9.06
COR annual interest coverage ratio is 9.06

Risk & Stability

Piotroski F-Score

5
COR piotroski f-score is 5

Altman Z-Score

4.60
COR altman z-score is 4.60

Analyst ratings

Recent major analysts updates

Apr 11, 25 B of A Securities
Neutral
Mar 14, 25 Wells Fargo
Equal-Weight
Feb 6, 25 Evercore ISI Group
Outperform
Jan 29, 25 Wells Fargo
Equal-Weight
Jan 24, 25 JP Morgan
Overweight
Dec 13, 24 Wells Fargo
Equal-Weight
Nov 7, 24 UBS
Buy
Nov 7, 24 Evercore ISI Group
Outperform
Nov 7, 24 Barclays
Overweight
Nov 7, 24 Baird
Outperform

Institutional Ownership

Similar stocks

UTHR logo
United Therapeutics (UTHR)
GMAB logo
Genmab A/S (GMAB)
INSM logo
Insmed Incorporated (INSM)
ALGN logo
Align Technology (ALGN)
DVA logo
DaVita (DVA)
HOLX logo
Hologic (HOLX)
ILMN logo
Illumina (ILMN)
THC logo
Tenet Healthcare (THC)
ICLR logo
ICON Public Limited (ICLR)
  • What is the ticker symbol for Cencora?
  • Does Cencora pay dividends?
  • What sector is Cencora in?
  • What industry is Cencora in?
  • What country is Cencora based in?
  • When did Cencora go public?
  • Is Cencora in the S&P 500?
  • Is Cencora in the NASDAQ 100?
  • Is Cencora in the Dow Jones?
  • When does Cencora report earnings?
  • Should I buy Cencora stock now?

What is the ticker symbol for Cencora?

The ticker symbol for Cencora is NYSE:COR

Does Cencora pay dividends?

No, Cencora does not pay dividends

What sector is Cencora in?

Cencora is in the Healthcare sector

What industry is Cencora in?

Cencora is in the Medical Distribution industry

What country is Cencora based in?

Cencora is headquartered in United States

When did Cencora go public?

Cencora's initial public offering (IPO) was on April 4, 1995

Is Cencora in the S&P 500?

Yes, Cencora is included in the S&P 500 index

Is Cencora in the NASDAQ 100?

No, Cencora is not included in the NASDAQ 100 index

Is Cencora in the Dow Jones?

No, Cencora is not included in the Dow Jones index

When does Cencora report earnings?

The date for Cencora's next earnings report has not been announced yet

Should I buy Cencora stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page